<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta name="viewport" content="width=device-width,initial-scale=1"><meta name="robots" content="noindex"><!-- Begin Jekyll SEO tag v2.8.0 --><title>Food and Drug Administration Takes First-Ever Enforcement Action To Ensure Clinical Trial Transparency, Following NYU Technology Law &amp; Policy Clinic’s Work with Universities Allied for Essential Medicines (UAEM)</title><meta name="generator" content="Jekyll v3.9.2"><meta property="og:title" content="Food and Drug Administration Takes First-Ever Enforcement Action To Ensure Clinical Trial Transparency, Following NYU Technology Law &amp; Policy Clinic’s Work with Universities Allied for Essential Medicines (UAEM)"><meta property="og:locale" content="en_US"><link rel="canonical" href="https://objectively.github.io/engelberg/news/food-and-drug-administration-takes-first-ever-enforcement-action-to-ensure-clinical-trial-transparency/"><meta property="og:url" content="https://objectively.github.io/engelberg/news/food-and-drug-administration-takes-first-ever-enforcement-action-to-ensure-clinical-trial-transparency/"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><meta property="twitter:title" content="Food and Drug Administration Takes First-Ever Enforcement Action To Ensure Clinical Trial Transparency, Following NYU Technology Law &amp; Policy Clinic’s Work with Universities Allied for Essential Medicines (UAEM)"><script type="application/ld+json">{"@context":"https://schema.org","@type":"WebPage","headline":"Food and Drug Administration Takes First-Ever Enforcement Action To Ensure Clinical Trial Transparency, Following NYU Technology Law &amp; Policy Clinic’s Work with Universities Allied for Essential Medicines (UAEM)","url":"https://objectively.github.io/engelberg/news/food-and-drug-administration-takes-first-ever-enforcement-action-to-ensure-clinical-trial-transparency/"}</script><!-- End Jekyll SEO tag --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:title" content="Food and Drug Administration Takes First-Ever Enforcement Action To Ensure Clinical Trial Transparency, Following NYU Technology Law &amp; Policy Clinic’s Work with Universities Allied for Essential Medicines (UAEM)"><meta name="twitter:description" content=""><title>Food and Drug Administration Takes First-Ever Enforcement Action To Ensure Clinical Trial Transparency, Following NYU Technology Law & Policy Clinic’s Work with Universities Allied for Essential Medicines (UAEM)</title><link rel="shortcut icon" href="/engelberg/images/favicon.ico" type="image/x-icon"><!-- <link rel="stylesheet" href="/engelberg/vendor/styleguide-v2.1.css"> --><link rel="stylesheet" href="/engelberg/vendor/foundation.min.css"><link rel="stylesheet" href="/engelberg/assets/style.min.css"><!-- <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet"> --><link href="https://fonts.googleapis.com/css?family=Material+Icons|Material+Icons+Outlined|Material+Icons+Two+Tone|Material+Icons+Round|Material+Icons+Sharp" rel="stylesheet"><link rel="preconnect" href="https://fonts.googleapis.com"><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link href="https://fonts.googleapis.com/css2?family=EB+Garamond:wght@400;700&family=Roboto+Condensed:wght@300;400;700&display=swap" rel="stylesheet"></head><body><a href="/engelberg/news/food-and-drug-administration-takes-first-ever-enforcement-action-to-ensure-clinical-trial-transparency/#main" class="skip-to-main-content-link">Skip to main content</a><header><nav class="main-nav"><img src="/engelberg/images/nyu-logo.svg" alt="New York University logo"> <span class="material-icons close-nav" tabindex="2">chevron_left</span> <a href="/engelberg/">Home</a> <a href="/engelberg/about">About</a> <a href="/engelberg/our-mission">Our Mission</a> <a href="/engelberg/our-people">Our People</a> <a href="/engelberg/what-we-do">What We Do</a> <a href="/engelberg/for-students">For Students</a> <a href="/engelberg/events">Events</a> <a href="/engelberg/products">Products</a> <a href="/engelberg/news">News</a> <a href="/engelberg/projects">Projects</a> <a href="/engelberg/getting-involved">Getting Involved</a></nav></header><header class="top-bar"><div class="top-bar__logo-container"><img class="logo" alt="logo" src="/engelberg/images/ec-icon-color.svg"></div></header><main id="main" class="announcement-page"><!-- Layout 2 --><div class="row expanded top-section"><div class="column large-4 medium-12 small-12"><div class="project__type">June 30, 2021</div><h1>Food and Drug Administration Takes First-Ever Enforcement Action To Ensure Clinical Trial Transparency, Following NYU Technology Law & Policy Clinic’s Work with Universities Allied for Essential Medicines (UAEM)</h1><div class="project__authors">Technology Law & Policy Clinic</div><div class="bar" style="background-image: url(//images.ctfassets.net/7yhm3nqs96oa/2D5uwTHX7ysJRgdPDJ5TGn/83c3cb8edce654c2cbc896dc864d84b1/bar-p.svg)"></div><div class="sidebar"><div class="news-image-wrapper"><img src="//images.ctfassets.net/7yhm3nqs96oa/7x4bDDsQ5By07YSgqkG2WP/260564eed5841ae5f00a61e78f665435/TLPc-purple.png" alt=""></div></div></div><div class="column large-7 large-offset-1 medium-12 small-12 no-padding markdown-content"><p><em>This post is part of a series exploring the Clinic’s work during the 2020-21 year</em></p><p>On April 28, 2021, the Food and Drug Administration (FDA) sent a <a href="https://www.fda.gov/media/148036/download">Notice of Noncompliance to Acceleron Pharma, Inc.</a> after the company failed to submit legally required clinical trial results to the public ClinicalTrials.gov database. This marks the <a href="https://www.fda.gov/news-events/press-announcements/fda-takes-action-failure-submit-required-clinical-trial-results-information-clinicaltrialsgov">first time the agency has ever taken such action</a> against a trial sponsor. In July of 2020, the FDA had requested that the manufacturer promptly submit Phase 2 clinical trial results for their experimental kidney cancer treatments, which the company failed to do.</p><p>FDA and the National Institutes of Health (NIH) share responsibility for enforcing the Food and Drug Administration Amendments Act (FDAAA) of 2007, the federal statute that requires trial sponsors to submit clinical trial results and other data to the ClinicalTrials.gov website. NIH then publishes the data for the benefit of patients, doctors, scientists, and the public at large. Over a decade has passed since FDAAA’s enactment, yet hundreds of trial sponsors continue to withhold results and other important data from the public because FDA and NIH have—until now—undertaken no meaningful enforcement.</p><p>FDA’s landmark step—sending its first-ever Notice of Noncompliance—follows ongoing efforts from <a href="https://www.uaem.org/">Universities Allied for Essential Medicines</a> (UAEM) in partnership with the NYU <a href="https://www.law.nyu.edu/academics/clinics/tech-law-policy">Technology Law and Policy (TLP) Clinic</a> to obtain relevant documents from the FDA and NIH through the Freedom of Information Act (FOIA). On March 10, 2021, the NYU TLP Clinic <a href="https://www.uaem.org/fda_enforces_clinical_trial_transparency_following_uaem_s_work">filed FOIA requests</a> on behalf of UAEM with both FDA and NIH. UAEM’s requests seek documentation of whether and how the agencies plan to begin meaningful enforcement. These requests build on <a href="http://www.altreroute.com/clinicaltrials/assets/download/UniversityTransparencyReport2019.pdf">UAEM’s joint research report with TranspariMed in 2019</a>, which reviewed the compliance of leading American universities in reporting their clinical trial results and found that a majority were noncompliant. Following publication of the 2019 report, the total number of fully compliant academic medical research institutions in the United States, among the top 40, increased from 13 in March 2019 to 17 in February 2021, as documented in <a href="http://altreroute.com/clinicaltrials/assets/download/Clinical_Trials_Transparency_Report_UAEM_v5.pdf">UAEM’s new report</a>, published in May 2021. Over the same period, these institutions’ percentage of unreported clinical trials decreased from 31% to 7%.</p><p>Through its FOIA requests, UAEM has demanded further information about FDA’s and NIH’s enforcement actions to date, including any pre-notice and non-compliance communications between the agencies and trial sponsors. In its ongoing FOIA investigation, UAEM has already gathered evidence that over an eight-year period, the FDA sent only a few dozen “pre-notice” letters to non-compliant trial sponsors. FDA’s Notice of Noncompliance is the first time that more meaningful enforcement action has been taken by either FDA or NIH, and it may signal that FDA is finally starting to take clinical trial transparency enforcement seriously.</p><p>UAEM and the NYU TLP Clinic will continue to work with both agencies on these FOIA requests.</p><p>In addition, Celine Rohr (’22) and Joe Rabinovitsj (’21), the TLP student attorneys on this project, together with Dr. Reshma Ramachandran, a UAEM board member, published an <a href="https://www.baltimoresun.com/opinion/op-ed/bs-ed-op-0514-fda-importance-20210513-x6cuesxc2ze5rogpkywledqlem-story.html">op-ed in <em>The Baltimore Sun</em></a> arguing that clinical trial transparency enforcement should be a priority for whoever becomes the next FDA commissioner.</p><p>TLP Clinic Deputy Director Christopher Morten supervised this project.</p></div></div></main><footer><div class="row expanded footer"><div class="column large-5 small-12"><img class="footer--logo" src="/engelberg/images/ec-logo.svg" alt="Engelberg Center logo"><p class="footer--about">Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.</p></div><div class="column large-4 large-offset-1 small-12"><span class="footer--section-title">Join Our Mailing List</span><div class="form"><!-- Begin Mailchimp Signup Form --><div id="mc_embed_signup"><form action="https://nyuengelberg.us3.list-manage.com/subscribe/post?u=fd77b1cbdc6e203814ed46c7a&amp;id=0bb7830d93&amp;f_id=008d4ae2f0" method="post" id="mc-embedded-subscribe-form" name="mc-embedded-subscribe-form" class="validate" target="_blank" novalidate><div id="mc_embed_signup_scroll"><div class="mc-field-group"><label class="visually-hidden" for="mce-EMAIL">Email Address <span class="asterisk">*</span></label> <input type="email" value="Email Address*" name="EMAIL" class="required email text-area" id="mce-EMAIL" required> <span id="mce-EMAIL-HELPERTEXT" class="helper_text"></span></div><div class="mc-field-group"><label class="visually-hidden" for="mce-FNAME">First Name</label> <input type="text" value="First Name" name="FNAME" class="" id="mce-FNAME"> <span id="mce-FNAME-HELPERTEXT" class="helper_text"></span></div><div class="mc-field-group"><label class="visually-hidden" for="mce-LNAME">Last Name</label> <input type="text" value="Last Name" name="LNAME" class="" id="mce-LNAME"> <span id="mce-LNAME-HELPERTEXT" class="helper_text"></span></div><div class="mc-field-group input-group"><strong>I am an NYU Law student or alumni</strong><ul><li><input type="radio" value="Yes" name="STU_ALUM" id="mce-STU_ALUM-0"> <label for="mce-STU_ALUM-0">Yes</label></li><li><input type="radio" value="No" name="STU_ALUM" id="mce-STU_ALUM-1"> <label for="mce-STU_ALUM-1">No</label></li></ul><span id="mce-STU_ALUM-HELPERTEXT" class="helper_text"></span></div><div class="mc-field-group"><label for="mce-YEAR" class="year-label">If yes, my graduation year is</label> <input type="text" value="Year" name="YEAR" class="" id="mce-YEAR"> <span id="mce-YEAR-HELPERTEXT" class="helper_text"></span></div><div id="mce-responses" class="clear"><div class="response" id="mce-error-response" style="display:none"></div><div class="response" id="mce-success-response" style="display:none"></div></div><!-- real people should not fill this in and expect good things - do not remove this or risk form bot signups--><div style="position: absolute; left: -5000px;" aria-hidden="true"><input type="text" name="b_fd77b1cbdc6e203814ed46c7a_0bb7830d93" tabindex="-1" value=""></div><div class="clear"><input type="submit" value="Submit" name="subscribe" id="mc-embedded-subscribe" class="button"></div></div></form></div><script type="text/javascript" src="//s3.amazonaws.com/downloads.mailchimp.com/js/mc-validate.js"></script><script type="text/javascript">(function($) {window.fnames = new Array(); window.ftypes = new Array();fnames[0]='EMAIL';ftypes[0]='email';fnames[1]='FNAME';ftypes[1]='text';fnames[2]='LNAME';ftypes[2]='text';fnames[7]='STU_ALUM';ftypes[7]='radio';fnames[8]='YEAR';ftypes[8]='text';fnames[3]='NYCBASE';ftypes[3]='radio';fnames[4]='MMERGE4';ftypes[4]='text';fnames[5]='MMERGE5';ftypes[5]='text';}(jQuery));var $mcj = jQuery.noConflict(true);</script><!--End mc_embed_signup--></div></div><div class="column large-2 small-12 footer--nav"><a href="/engelberg/">Home</a> <a href="/engelberg/our-mission">Our Mission</a> <a href="/engelberg/our-people">Our People</a> <a href="/engelberg/what-we-do">What We Do</a> <a href="/engelberg/for-students">For Students</a> <a href="/engelberg/events">Events</a> <a href="/engelberg/products">Products</a> <a href="/engelberg/news">News</a> <a href="/engelberg/projects">Projects</a> <a href="/engelberg/getting-involved">Getting Involved</a></div></div></footer><div class="copyright"><div class="row expanded"><div class="column large-10 small-12"><span class="copyright--top-text">Engelberg Center on Innovation Law & Policy</span> <span class="copyright--bottom-text"><span>139 MacDougal Street Room 408, New York, NY 10012</span> <span class="copyright--bottom-text__number">212.998.6013</span> <span><a href="mailto:engelberg.center@nyu.edu">engelberg.center@nyu.edu</a></span></span></div><div class="column large-2 small-12"><img class="footer--logo" src="/engelberg/images/nyu-logo.svg" alt="New York University logo"></div></div></div><div id="overlay" class="js-overlay"></div><script src="https://code.jquery.com/jquery-3.4.1.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><script type="text/javascript" src="/engelberg/vendor/twitterFetcher_min.js"></script><script src="/engelberg/assets/bundle.js"></script></body></html>